Your browser doesn't support javascript.
loading
IL6/STAT3 axis mediates resistance to BRAF inhibitors in thyroid carcinoma cells.
Notarangelo, Tiziana; Sisinni, Lorenza; Trino, Stefania; Calice, Giovanni; Simeon, Vittorio; Landriscina, Matteo.
Afiliación
  • Notarangelo T; Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy.
  • Sisinni L; Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy.
  • Trino S; Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy.
  • Calice G; Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy.
  • Simeon V; Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy; Medical Statistics Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Landriscina M; Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy; Medical Oncology Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy. Electronic address: matteo.landriscina@unifg.it.
Cancer Lett ; 433: 147-155, 2018 10 01.
Article en En | MEDLINE | ID: mdl-29969659

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Interleucina-6 / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas B-raf / Factor de Transcripción STAT3 / Vemurafenib Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Lett Año: 2018 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Interleucina-6 / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas B-raf / Factor de Transcripción STAT3 / Vemurafenib Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Lett Año: 2018 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Irlanda